TipRanks
Advertisement
Advertisement

SE:ACE Stock Latest News

Ascelia Pharma’s Orviglance Study Published in Leading MRI Journal
Company AnnouncementsAscelia Pharma’s Orviglance Study Published in Leading MRI Journal
14d ago
Ascelia Pharma Holds FDA Type A Meeting on Orviglance NDA
PremiumCompany Announcements
Ascelia Pharma Holds FDA Type A Meeting on Orviglance NDA
28d ago
Ascelia Pharma Tightens Costs After FDA Setback on Orviglance
PremiumCompany Announcements
Ascelia Pharma Tightens Costs After FDA Setback on Orviglance
2M ago
Ascelia Pharma Secures FDA Type A Meeting on Orviglance NDA
PremiumCompany Announcements
Ascelia Pharma Secures FDA Type A Meeting on Orviglance NDA
2M ago
Ascelia Pharma Restructures and Cuts Costs to Sharpen Focus on Orviglance
PremiumCompany Announcements
Ascelia Pharma Restructures and Cuts Costs to Sharpen Focus on Orviglance
3M ago
Ascelia Pharma Defends Orviglance Data After FDA Complete Response Letter
PremiumCompany AnnouncementsAscelia Pharma Defends Orviglance Data After FDA Complete Response Letter
3M ago
Ascelia Pharma Receives FDA Complete Response Letter on Orviglance NDA
Premium
Company Announcements
Ascelia Pharma Receives FDA Complete Response Letter on Orviglance NDA
3M ago
Ascelia Pharma Bolsters Orviglance Franchise with New Patent Filing
Premium
Company Announcements
Ascelia Pharma Bolsters Orviglance Franchise with New Patent Filing
3M ago
Ascelia Showcases Orviglance MRI Data at ESGAR 2026 Amid FDA Review
PremiumCompany Announcements
Ascelia Showcases Orviglance MRI Data at ESGAR 2026 Amid FDA Review
4M ago
Ascelia Pharma Nears FDA Decision on Orviglance and Bolsters Finances for Partnering Push
PremiumCompany Announcements
Ascelia Pharma Nears FDA Decision on Orviglance and Bolsters Finances for Partnering Push
5M ago
Ascelia Pharma AGM Backs Incentive Plan but Rejects Share Issue Mandate
PremiumCompany Announcements
Ascelia Pharma AGM Backs Incentive Plan but Rejects Share Issue Mandate
5M ago
Ascelia Pharma Expands Share Capital After Directed New Issue
PremiumCompany Announcements
Ascelia Pharma Expands Share Capital After Directed New Issue
5M ago
Ascelia Pharma Raises SEK 20 Million in Directed Share Issue Ahead of Orviglance Milestone
PremiumCompany AnnouncementsAscelia Pharma Raises SEK 20 Million in Directed Share Issue Ahead of Orviglance Milestone
6M ago
Ascelia Pharma Eyes Transformative 2026 With Orviglance FDA Review
Premium
Company Announcements
Ascelia Pharma Eyes Transformative 2026 With Orviglance FDA Review
6M ago
Ascelia Pharma Calls 2026 AGM, Proposes No Dividend and New Incentive Plan
Premium
Company Announcements
Ascelia Pharma Calls 2026 AGM, Proposes No Dividend and New Incentive Plan
6M ago
Ascelia’s Liver Imaging Agent Orviglance Selected for Key ESGAR 2026 Presentation
PremiumCompany Announcements
Ascelia’s Liver Imaging Agent Orviglance Selected for Key ESGAR 2026 Presentation
6M ago
Ascelia Pharma’s Orviglance NDA Accepted by FDA as Cash Runway Extends Beyond 2026 Decision
PremiumCompany Announcements
Ascelia Pharma’s Orviglance NDA Accepted by FDA as Cash Runway Extends Beyond 2026 Decision
8M ago
Ascelia Pharma Deputy CEO and CFO Julie Waras Brogren to Depart for New CEO Role
PremiumCompany Announcements
Ascelia Pharma Deputy CEO and CFO Julie Waras Brogren to Depart for New CEO Role
9M ago
Ascelia Pharma Appoints Nomination Committee Ahead of 2026 AGM
PremiumCompany Announcements
Ascelia Pharma Appoints Nomination Committee Ahead of 2026 AGM
10M ago
Ascelia Pharma Adjusts Share Structure Following Share Saving Program
PremiumCompany AnnouncementsAscelia Pharma Adjusts Share Structure Following Share Saving Program
10M ago
Ascelia Pharma Converts Series C Shares to Ordinary Shares for Incentive Program
Premium
Company Announcements
Ascelia Pharma Converts Series C Shares to Ordinary Shares for Incentive Program
11M ago
FDA Accepts Ascelia Pharma’s Orviglance NDA for Review
Premium
Company Announcements
FDA Accepts Ascelia Pharma’s Orviglance NDA for Review
11M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >